Neuberger Berman Group LLC Care Dx, Inc. Transaction History

Neuberger Berman Group LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.49 - $39.72 $1.21 Million - $2.35 Million	-59,225 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$28.19 - $46.6 $16,547 - $27,354	587 Added 1.0%	59,225 $2.17 Million
Q4 2021 Feb 11, 2022	SELL	$41.2 - $73.6 $1.46 Million - $2.61 Million	-35,439 Reduced 37.67%	58,638 $2.63 Million
Q3 2021 Nov 12, 2021	BUY	$59.15 - $91.99 $34,307 - $53,354	580 Added 0.62%	94,077 $5.96 Million
Q2 2021 Aug 13, 2021	BUY	$63.02 - $95.11 $2.03 Million - $3.06 Million	32,225 Added 52.59%	93,497 $8.55 Million
Q1 2021 May 13, 2021	BUY	$57.62 - $95.6 $2.95 Million - $4.9 Million	51,272 Added 512.72%	61,272 $4.17 Million
Q2 2020 Aug 13, 2020	SELL	$18.95 - $35.43 $8.12 Million - $15.2 Million	-428,405 Reduced 97.72%	10,000 $354,000
Q1 2020 May 14, 2020	BUY	$13.94 - $28.25 $5.97 Million - $12.1 Million	428,403 Added 4283.17%	438,405 $9.57 Million
Q4 2019 Feb 12, 2020	BUY	$19.24 - $28.41 $192,438 - $284,156	10,002 New	10,002 $216,000
Q1 2019 May 13, 2019	SELL	$22.09 - $39.21 $530,160 - $941,040	-24,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$19.89 - $30.02 $477,360 - $720,480	24,000 New	24,000 $603,000

157

53.5M

60.8K

34.9K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.59B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.